article thumbnail

White Bagging Update 2022: Hospitals Battle to Boost Buy-and-Bill

Drug Channels

However, buy-and-bill appears to have rebounded substantially at hospitals. As I explain below, this resurgence likely reflects the success of vertically-integrated hospital/specialty pharmacy/physician mega-systems against the large insurer/PBM/specialty pharmacy/provider mega-organizations. d/b/a Drug Channels Institute.

article thumbnail

Damon Runyon launches new pediatric cancer fellowship in partnership with St. Jude Children’s Research Hospital

SCIENMAG: Medicine & Health

Jude Children’s Research Hospital announced a new pediatric-focused fellowship today. The initiative aims to help address the critical shortage of top young scientists who often seek more prevalent opportunities in adult cancer research or the pharmaceutical sector. […]

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Channels News Roundup, October 2021: PBMs’ Oncology Exclusions, Biosimilar Boom, BCBS vs. Hospitals, U.S. vs. the World, and CRISPR Comedy

Drug Channels

Scream as Blue Cross Blue Shield frightfully overpays hospitals Shocking! PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! Brrr.did you hear that? It’s the biosimilar boom! Believe it or not, U.S Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

article thumbnail

NEW: The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. contains new data on hospital acquisitions and consolidation activity. Section 6.1.6.

article thumbnail

Recce Pharmaceuticals’ synthetic approach to combatting AMR

Drug Target Review

R327 was studied against several Gram-negative and Gram-positive microbial species, including the ESKAPE pathogens, a group of highly resistant bacteria and the leading cause of hospital-acquired infections globally. About the author James Graham, CEO of Recce Pharmaceuticals Recce Pharmaceuticals.

article thumbnail

NEW: The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. So, you can find out what your customers, partners, and competitors are reading.

article thumbnail

Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis (rerun)

Drug Channels

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.